Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
autoimmune diseases
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cell therapy
detroit blog main
detroit top stories
genfit
3
×
indiana blog main
indiana top stories
investing
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
aquestive therapeutics
arch venture partners
arimoclomol
What
bio
roundup
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
efforts
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
advantages
bar
brings
drug
expect
gamble
market
medco’s
mover
new
patients
payers
physicians
plan
pricing
sets
type
ubiome
undone
Language
unset
Current search:
genfit
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone